Pfizer Says Its COVID Vaccine Is 90.7% Effective In Kids Ages 5 To 11

The video discusses booster recommendations for COVID-19 vaccines and Pfizer's progress in vaccinating children aged 5 to 11, highlighting the vaccine's 90% efficacy. Dr. Hilary Fairbrother emphasizes the importance of vaccinating children despite their typically mild COVID-19 symptoms, drawing parallels with other pediatric vaccines like chickenpox. The discussion also covers the safety of the vaccine, noting fewer side effects in younger children. Future plans for vaccinating children aged 6 months to 5 years are also mentioned, with expectations for early 2022 approval.

What is the significance of the chickenpox vaccine mentioned in the text?

What concerns are raised about the potential side effects of the vaccine in younger children?